Linda Gardner

Mrs. Linda Gardner has over two decades of Interventional Radiology experience, prior to transitioning over to Nuclear Medicine in March of 2017. She is the Chief Nurse for the Peptide Receptor Radionuclide Therapy (PRRT) program, starting from the expanded access program (EAP) thru to the FDA approved commercial program. She has presented this program to a national, and international audience. Linda Gardner was the Chief Research Nurse for the Lu 177-PSMA-directed endo-radiotherapy of metastatic, castration-resistant prostate cancer clinical phase 2 trial at UCLA. UCLA has been one of the first institutions to administer Lu-177 PSMA-617 under the MAP (Managed access program) which is currently awaiting FDA approval. Linda Gardner is leading the ICPO Academy pillar for Nursing and Patients Relationships.